Elekta AB (MEX:EKTAB N) Research & Development: MXN5,050 Mil (TTM As of Apr. 2026)


MEX:EKTAB N Elekta AB MEX:EKTAB N
79 GF Score
Price MXN126.63
GF Value MXN158.57
! 6 Warning Signs
View Full Analysis

What is Elekta AB Research & Development?

Elekta AB MEX:EKTAB N 79 Research & Development is MXN5,050 Mil as of Apr. 2026. GuruFocus rates MEX:EKTAB N with a GF Score™ of 79/100 and a GF Value™ of MXN158.57. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Elekta AB's Research & Development for the three months ended in Apr. 2026 was MXN2,341 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was MXN5,050 Mil.

Elekta AB  (MEX:EKTAB N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Elekta AB Research & Development Related Terms

Elekta AB Research & Development Historical Data

* Premium members only.

The historical data trend for Elekta AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB Research & Development Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,922.27 2,464.76 2,215.11 5,366.96 4,975.77

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,759.69 857.84 854.00 996.33 2,341.43
MEX:EKTAB N
79GF Score
Elekta AB MEX:EKTAB N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,050 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN5,050 Mil mean?
Elekta AB (MEX:EKTAB N) has a Research & Development of MXN5,050 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Elekta AB and its competitors.
Is Elekta AB's Research & Development too high?
Elekta AB's current Research & Development is MXN5,050 Mil. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's Research & Development compare to ABT and SYK?
Elekta AB's Research & Development of MXN5,050 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Elekta AB and its competitors. Elekta AB's current Research & Development is MXN5,050 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current Research & Development of MXN5,050 Mil. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current Research & Development is MXN5,050 Mil. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current Research & Development is MXN5,050 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.

Key valuation signals for MEX:EKTAB N:

  • Research & Development: MXN5,050 Mil
  • GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score

Get the complete analysis for MEX:EKTAB N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN158.57
GF Value